Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
about
Agonist-induced down-regulation of endogenous protein kinase c α through an endolysosomal mechanism.Is There Potential for Repurposing Statins as Novel Antimicrobials?A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection.Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.Morphological and proliferative abnormalities in renal mesangial cells lacking RhoGDI.
P2860
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
@en
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
@nl
type
label
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
@en
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
@nl
prefLabel
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
@en
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
@nl
P2860
P356
P1476
Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity.
@en
P2093
Aimee M deCathelineau
Gary M Bokoch
P2860
P304
P356
10.1128/IAI.01005-08
P407
P577
2008-10-20T00:00:00Z